Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon in elderly subjects with chronic insomnia
NCT00671255Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2002
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of ramelteon in Insomnia (3 arms), sponsored by Takeda. Primary endpoint: Subjective Sleep Latency at 1 week. Started Dec 2002; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00671255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671255.